APA (7 वां संस्करण) प्रशस्ति पत्र

(22686224), X. G., (22509188), J. G., (10054227), H. S., (119096), Q. C., (504321), Y. Y., & (290758), B. L. (2025). Data Sheet 1_Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC.docx.

शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र

(22686224), Xinhang Gu, Jiaxiao Geng (22509188), Hongfu Sun (10054227), Qiang Cao (119096), Yan Yi (504321), और Baosheng Li (290758). Data Sheet 1_Effect, Safety, Timing and Dose of Thoracic Radiotherapy Plus Third-generation EGFR-TKIs as First-line Treatment in Patients with EGFR-mutated Oligo-organ Metastatic NSCLC.docx. 2025.

एमएलए (9वां संस्करण) प्रशस्ति पत्र

(22686224), Xinhang Gu, et al. Data Sheet 1_Effect, Safety, Timing and Dose of Thoracic Radiotherapy Plus Third-generation EGFR-TKIs as First-line Treatment in Patients with EGFR-mutated Oligo-organ Metastatic NSCLC.docx. 2025.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.